Ingevity Corporation manufactures and sells specialty chemicals and carbon materials in the United States and internationally. The company operates through two segments, Performance Materials and Performance Chemicals. The Performance Materials segment engineers, manufactures, and sells wood-based chemically activated carbon products primarily for gasoline vapor emission control systems. This segment also produces other activated carbon products for use in various applications, including food, water, beverage, and chemical purification. The Performance Chemicals segment develops, manufactures, and sells a range of specialty chemicals derived from co-products of the Kraft pulping process. This segment's products are used in various applications comprising asphalt paving, oilfield exploration and production, printing inks, adhesives, agrochemical dispersants, lubricants, and other diverse industries. Ingevity Corporation was incorporated in 2015 and is headquartered in North Charleston, South Carolina.
Industry, Sector and Symbol
Stock Exchange NYSE
Industry Chemicals & allied products
Sub-IndustryN/A
SectorBasic Materials
Current SymbolNYSE:NGVT
Previous SymbolNASDAQ:NGVT
CUSIPN/A
Phone843-740-2300
Debt
Debt-to-Equity Ratio2.31
Current Ratio2.34
Quick Ratio1.26
Price-To-Earnings
Trailing P/E Ratio36.41
Forward P/E Ratio24.30
P/E Growth2.15
Sales & Book Value
Annual Sales$972.40 million
Price / Sales4.04
Cash Flow$3.3715 per share
Price / Cash27.75
Book Value$6.60 per share
Price / Book14.18
Profitability
EPS (Most Recent Fiscal Year)$2.58
Net Income$126.50 million
Net Margins15.53%
Return on Equity47.45%
Return on Assets12.51%
Miscellaneous
Employees1,500
Outstanding Shares41,970,000
Market Cap$4.16 billion
OptionableOptionable
Ingevity (NYSE:NGVT) Frequently Asked Questions
What is Ingevity's stock symbol?
Ingevity trades on the New York Stock Exchange (NYSE) under the ticker symbol "NGVT."
How were Ingevity's earnings last quarter?
Ingevity Corp (NYSE:NGVT) announced its quarterly earnings results on Wednesday, October, 24th. The company reported $1.16 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.04 by $0.12. The business had revenue of $311.20 million for the quarter, compared to analyst estimates of $305.50 million. Ingevity had a return on equity of 47.45% and a net margin of 15.53%. View Ingevity's Earnings History.
When is Ingevity's next earnings date?
What price target have analysts set for NGVT?
8 brokerages have issued 12-month price targets for Ingevity's shares. Their forecasts range from $90.00 to $110.00. On average, they expect Ingevity's stock price to reach $101.50 in the next twelve months. This suggests a possible upside of 8.5% from the stock's current price. View Analyst Price Targets for Ingevity.
What is the consensus analysts' recommendation for Ingevity?
8 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Ingevity in the last year. There are currently 2 hold ratings and 6 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Ingevity.
Has Ingevity been receiving favorable news coverage?
Press coverage about NGVT stock has been trending positive recently, InfoTrie Sentiment reports. The research firm identifies negative and positive news coverage by reviewing more than six thousand blog and news sources. The firm ranks coverage of public companies on a scale of -5 to 5, with scores closest to five being the most favorable. Ingevity earned a news sentiment score of 2.8 on InfoTrie's scale. They also assigned news headlines about the company a news buzz of 10.0 out of 10, meaning that recent news coverage is extremely likely to have an effect on the company's share price in the next several days.
Who are some of Ingevity's key competitors?
Some companies that are related to Ingevity include Koninklijke DSM (RDSMY), ASAHI KASEI Cor/ADR (AHKSY), FMC (FMC), Johnson Matthey (JMPLY), KURARAY Co Ltd/ADR (KURRY), Ashland Global (ASH), Chemours (CC), Huntsman (HUN), W. R. Grace & Co (GRA), Olin (OLN), Univar (UNVR), Balchem (BCPC), PQ Group (PQG), GCP Applied Technologies (GCP) and Innospec (IOSP).
Who are Ingevity's key executives?
Ingevity's management team includes the folowing people:
- Mr. D. Michael Wilson, Pres, CEO & Director (Age 55)
- Mr. John C. Fortson, Exec. VP, CFO & Treasurer (Age 51)
- Ms. Katherine Pryor Burgeson, Exec. VP, Gen. Counsel & Sec. (Age 60)
- Mr. Stuart Edward Woodcock Jr., Exec. VP & Pres of Performance Materials (Age 52)
- Mr. Michael P. Smith, Exec. VP and Pres of Performance Chemicals, Strategy & Bus. Devel. (Age 57)
Who are Ingevity's major shareholders?
Ingevity's stock is owned by a number of of retail and institutional investors. Top institutional shareholders include BlackRock Inc. (14.52%), Franklin Resources Inc. (3.69%), FMR LLC (2.06%), Loomis Sayles & Co. L P (1.86%), Wells Fargo & Company MN (1.85%) and Channing Capital Management LLC (1.60%). View Institutional Ownership Trends for Ingevity.
Which major investors are selling Ingevity stock?
NGVT stock was sold by a variety of institutional investors in the last quarter, including Massachusetts Financial Services Co. MA, Franklin Resources Inc., Renaissance Technologies LLC, Channing Capital Management LLC, Patten & Patten Inc. TN, American Century Companies Inc., Prudential Financial Inc. and WINTON GROUP Ltd. View Insider Buying and Selling for Ingevity.
Which major investors are buying Ingevity stock?
NGVT stock was acquired by a variety of institutional investors in the last quarter, including Wells Fargo & Company MN, Pictet Asset Management Ltd., Neuberger Berman Group LLC, Bamco Inc. NY, BlackRock Inc., Eagle Asset Management Inc., Royce & Associates LP and EAM Investors LLC. View Insider Buying and Selling for Ingevity.
How do I buy shares of Ingevity?
Shares of NGVT can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Ingevity's stock price today?
One share of NGVT stock can currently be purchased for approximately $93.56.
How big of a company is Ingevity?
Ingevity has a market capitalization of $4.16 billion and generates $972.40 million in revenue each year. The company earns $126.50 million in net income (profit) each year or $2.58 on an earnings per share basis. Ingevity employs 1,500 workers across the globe.
What is Ingevity's official website?
How can I contact Ingevity?
Ingevity's mailing address is 5255 VIRGINIA AVENUE, NORTH CHARLESTON SC, 29406. The company can be reached via phone at 843-740-2300 or via email at [email protected]
MarketBeat Community Rating for Ingevity (NYSE NGVT)
MarketBeat's community ratings are surveys of what our community members think about Ingevity and other stocks. Vote "Outperform" if you believe NGVT will outperform the S&P 500 over the long term. Vote "Underperform" if you believe NGVT will underperform the S&P 500 over the long term. You may vote once every thirty days.
